Drug
Ro6889450
Ro6889450: highest development phase Phase 1, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| RO6889450 NCT02699372 | Phase 1 | Healthy Volunteer |
Latest
No recent events.
Follow Ro6889450 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.